Identification and characterization of compounds that potentiate NT-3-mediated Trk receptor activity

Molecular Pharmacology

Volumn 69, Issue 4, 2006, Pages 1396-1404

  Lewis, Martin A ^a   Hunihan, Lisa ^a   Franco, Diana ^a   Robertson, Barbara ^a   Palmer, Jane ^a   St Laurent, Denis R ^a   Balasubramanian, Balu N ^a   Li, Yi ^a   Westphal, Ryan S ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

13 [6 DEOXY 6[( 2,5 DIAMINO 1 OXOPENTYL)AMINO] BETA DEXTRO GLUCOPYRANOSYL] 3,9 DIFLUORO [1]BENZOTHIENO[2,3 A]PYROLO[3,4 C]CARBAZOLE 5,7 (6H,13H) DIONE; BETA LACTAMASE; CARBAZOLE DERIVATIVE; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN 3; PROTEIN TYROSINE KINASE B RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; CRICETINAE; DNA, COMPLEMENTARY; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROTROPHIN 3; PHOSPHORYLATION; RATS; RECEPTOR, TRKB; SIGNAL TRANSDUCTION;

EID: 33645101155     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.020255     Document Type: Article

References (37)

1. Bibel M and Barde YA (2000) Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14:2919-2937.
2. Bothwell M (1995) Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 18:223-253.
3. Burstein DE, Blumberg PM, and Greene LA (1982) Nerve growth factor-induced neuronal differentiation of PC12 pheochromocytoma cells: lack of inhibition by a tumor promoter. Brain Res 247:115-119.
4. Coppola V, Kucera J, Palko ME, Martinez-De Velasco J, Lyons WE, Fritzsch B, and Tessarollo L (2001) Dissection of NT3 functions in vivo by gene replacement strategy. Development 128:4315-4327.
5. Cowley S, Paterson H, Kemp P, and Marshall CJ (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
6. Cunningham ME, Stephens RM, Kaplan DR, and Greene LA (1997) Autophosphorylation of activation loop tyrosines regulates signaling by the TRK nerve growth factor receptor. J Biol Chem 272:10957-10967.
7. Dawbarn D and Allen SJ (2003) Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 29:211-230.
8. Dechant G and Neumann H (2002) Neurotrophins. Adv Exp Med Biol 513:303-334.
9. Duman RS, Heninger GR, and Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
10. Durany N and Thome J (2004) Neurotrophic factors and the pathophysiology of schizophrenic psychoses. Eur Psychiatry 19:326-337.
11. Fukuda M, Gotoh Y, Tachibana T, Dell K, Hattori S, Yoneda Y, and Nishida E (1995) Induction of neurite outgrowth by MAP kinase in PC12 cells. Oncogene 11:239-244.
12. Greene LA and Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428.
13. Horton RM (1997) In vitro recombination and mutagenesis of DNA. SOEing together tailor-made genes. Methods Mol Biol 67:141-149.
14. Huang EJ and Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609-642.
15. Ibanez CF, Ilag LL, Murray-Rust J, and Persson H (1993) An extended surface of binding to Trk tyrosine kinase receptors in NGF and BDNF allows the engineering of a multifunctional pan-neurotrophin. EMBO (Eur Mol Biol Organ) J 12:2281-2293.
16. Kaplan DR and Miller FD (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381-391.
17. Kelly-Spratt KS, Klesse LJ, and Parada LF (2002) BDNF activated TrkB/IRR receptor chimera promotes survival of sympathetic neurons through Ras and PI-3 kinase signaling. J Neurosci Res 69:151-159.
18. Lang UE, Jockers-Scherubl MC, and Hellweg R (2004) State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J Neural Transm 111:387-411.
19. Lazarovici P, Jiang H, and Fink D Jr (1998) The 38-amino-acid form of pituitary adenylate cyclase-activating polypeptide induces neurite outgrowth in PC12 cells that is dependent on protein kinase C and extracellular signal-regulated kinase but not on protein kinase A, nerve growth factor receptor tyrosine kinase, p21(ras) G protein and pp60(c-src) cytoplasmic tyrosine kinase. Mol Pharmacol 54:547-558.
20. Maroney AC, Finn JP, Bozyczko-Coyne D, O'Kane TM, Neff NT, Tolkovsky AM, Park DS, Yan CY, Troy CM, and Greene LA (1999) CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. J Neurochem 73:1901-1912.
21. Maroney AC, Lipfert L, Forbes ME, Glicksman MA, Neff NT, Siman R, and Dionne CA (1995) K-252a induces tyrosine phosphorylation of the focal adhesin kinase and neurite outgrowth in human neuroblastoma SH-SY5Y cells. J Neurochem 64:540-549.
22. Maroney AC, Sanders C, Neff NT, and Dionne CA (1997) K-252b potentiation of neurotrophin-3 is trkA specific in cells lacking p75NTR. J Neurochem 68:88-94.
23. Middlemas DS, Meisenhelder J, and Hunter T (1994) Identification of TrkB autophosphorylation sites and evidence that phospholipase C-γ1 is a substrate of the TrkB receptor. J Biol Chem 269:5458-5466.
24. Pang L, Sawada T, Decker SJ, and Saltiel AR (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270:13585-13588.
25. Patapoutian A and Reichardt LF (2001) Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 11:272-280.
26. Pollack SJ and Harper SJ (2002) Trk neurotrophin receptor activators. Drug News Perspect 15:268-277.
27. Pollack S, Young L, Bilsland J, Wilkie N, Ellis S, Hefti F, Broughton H, and Harper S (1999) The staurosporine-like compound L-753,000 (NB-506) potentiates the neurotrophic effects of neurotrophin-3 by acting selectively at the TrkA receptor. Mol Pharmacol 56:185-195.
28. Ryden M and Ibanez CF (1996) Binding of neurotrophin-3 to p75LNGFR, TrkA and TrkB mediated by a single functional epitope distinct from that recognized by trkC. J Biol Chem 271:5623-5627.
29. Schramm M, Falkai P, Feldmann N, Knable MB, and Bayer TA (1998) Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia. Neurosci Lett 257:65-68.
30. Shirayama Y, Chen AC, Nakagawa S, Russell DS, and Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261.
31. Siuciak JA, Lewis DR, Wiegand SJ, and Lindsay RM (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56:131-137.
32. Snider WD, Zhou FQ, Zhong J, and Markus A (2002) Signaling the pathway to regeneration. Neuron 35:13-16.
33. Terry AV Jr and Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821-827.
34. Tessarollo L (1998) Pleiotropic functions of neurotrophins in development. Cytokine Growth Factor Rev 9:125-137.
35. Tessarollo L, Tsoulfas P, Donovan MJ, Palko ME, Blair-Flynn J, Hempstead BL, and Parada LF (1997) Targeted deletion of all isoforms of the trkC gene suggests the use of alternate receptors by its ligand neurotrophin-3 in neuronal development and implicates trkC in normal cardiogenesis. Proc Natl Acad Sci USA 94:14776-14781.
36. Treanor JJ, Schmelzer C, Knusel B, Winslow JW, Shelton DL, Hefti F, Nikolics K, and Burton LE (1995) Heterodimeric neurotrophins induce phosphorylation of Trk receptors and promote neuronal differentiation in PC12 cells. J Biol Chem 270:23104-23110.
37. Wilkie N, Wingrove PB, Bilsland JG, Young L, Harper SJ, Hefti F, Ellis S, and Pollack SJ (2001) The non-peptidyl fungal metabolite L-783,281 activates TRK neurotrophin receptors. J Neurochem 78:1135-1145.